Global Closed System Drug Transfer Device Market Overview:
Global Closed System Drug Transfer Device Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Closed System Drug Transfer Device Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Closed System Drug Transfer Device involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Closed System Drug Transfer Device Market:
The Closed System Drug Transfer Device Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Closed System Drug Transfer Device Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Closed System Drug Transfer Device Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Closed System Drug Transfer Device market has been segmented into:
Membrane to Membrane and Needleless System
By Application, Closed System Drug Transfer Device market has been segmented into:
Vial Access Devices
Syringe Safety Devices
Accessories
Bag/Line Access Devices
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Closed System Drug Transfer Device market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Closed System Drug Transfer Device market.
Top Key Players Covered in Closed System Drug Transfer Device market are:
Braun SE (Germany)
JMS Co.
Ltd. (Japan)
ICU Medical
Inc. (US)
Simplivia (Israel)
Equashield (US)
Becton
Dickinson and Company (US)
Baxter International Inc. (US)
Cormed (US)
Yukon Medical (US)
Caragen Ltd. (Ireland)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Closed System Drug Transfer Device Market Type
4.1 Closed System Drug Transfer Device Market Snapshot and Growth Engine
4.2 Closed System Drug Transfer Device Market Overview
4.3 Membrane to Membrane and Needleless System
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Membrane to Membrane and Needleless System: Geographic Segmentation Analysis
Chapter 5: Closed System Drug Transfer Device Market Application
5.1 Closed System Drug Transfer Device Market Snapshot and Growth Engine
5.2 Closed System Drug Transfer Device Market Overview
5.3 Vial Access Devices
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Vial Access Devices: Geographic Segmentation Analysis
5.4 Syringe Safety Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Syringe Safety Devices: Geographic Segmentation Analysis
5.5 Accessories
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Accessories: Geographic Segmentation Analysis
5.6 Bag/Line Access Devices
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Bag/Line Access Devices: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Closed System Drug Transfer Device Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BRAUN SE (GERMANY)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 JMS CO.
6.4 LTD. (JAPAN)
6.5 ICU MEDICAL
6.6 INC. (US)
6.7 SIMPLIVIA (ISRAEL)
6.8 EQUASHIELD (US)
6.9 BECTON
6.10 DICKINSON AND COMPANY (US)
6.11 BAXTER INTERNATIONAL INC. (US)
6.12 CORMED (US)
6.13 YUKON MEDICAL (US)
6.14 CARAGEN LTD. (IRELAND)
Chapter 7: Global Closed System Drug Transfer Device Market By Region
7.1 Overview
7.2. North America Closed System Drug Transfer Device Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Membrane to Membrane and Needleless System
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Vial Access Devices
7.2.3.2 Syringe Safety Devices
7.2.3.3 Accessories
7.2.3.4 Bag/Line Access Devices
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Closed System Drug Transfer Device Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Membrane to Membrane and Needleless System
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Vial Access Devices
7.3.3.2 Syringe Safety Devices
7.3.3.3 Accessories
7.3.3.4 Bag/Line Access Devices
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Closed System Drug Transfer Device Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Membrane to Membrane and Needleless System
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Vial Access Devices
7.4.3.2 Syringe Safety Devices
7.4.3.3 Accessories
7.4.3.4 Bag/Line Access Devices
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Closed System Drug Transfer Device Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Membrane to Membrane and Needleless System
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Vial Access Devices
7.5.3.2 Syringe Safety Devices
7.5.3.3 Accessories
7.5.3.4 Bag/Line Access Devices
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Closed System Drug Transfer Device Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Membrane to Membrane and Needleless System
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Vial Access Devices
7.6.3.2 Syringe Safety Devices
7.6.3.3 Accessories
7.6.3.4 Bag/Line Access Devices
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Closed System Drug Transfer Device Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Membrane to Membrane and Needleless System
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Vial Access Devices
7.7.3.2 Syringe Safety Devices
7.7.3.3 Accessories
7.7.3.4 Bag/Line Access Devices
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Closed System Drug Transfer Device Scope:
|
Report Data
|
Closed System Drug Transfer Device Market
|
|
Closed System Drug Transfer Device Market Size in 2025
|
USD XX million
|
|
Closed System Drug Transfer Device CAGR 2025 - 2032
|
XX%
|
|
Closed System Drug Transfer Device Base Year
|
2024
|
|
Closed System Drug Transfer Device Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Braun SE (Germany), JMS Co., Ltd. (Japan), ICU Medical, Inc. (US), Simplivia (Israel), Equashield (US), Becton, Dickinson and Company (US), Baxter International Inc. (US), Cormed (US), Yukon Medical (US), Caragen Ltd. (Ireland).
|
|
Key Segments
|
By Type
Membrane to Membrane and Needleless System
By Applications
Vial Access Devices
Syringe Safety Devices
Accessories
Bag/Line Access Devices
|
